1.
The Effect of In-Hospital Intervention to Reduce Door to Needle Time in Patients Receiving Tissue Plasminogen Activator. J. Intellect. Disabl. Diagn. Treat. [Internet]. 2020 May 15 [cited 2026 Jan. 17];8(2):112-6. Available from: https://neolifescience.com/index.php/jiddt/article/view/6741